Common side effects of Orap include: akathisia, akinesia, sedation, and visual disturbance.  See below for a comprehensive list of adverse effects.
As well as its needed effects, pimozide (the active ingredient contained in Orap) may cause unwanted side effects that require medical attention. 
Some pimozide side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
The most common side effects include somnolence, hyperhidrosis, nocturia, and dizziness.
Very common (10% or more): Somnolence (up to 25%), dizziness (up to 11%)Common (1% to 10%): Extrapyramidal disorder, akathisia, headache, lethargy, tremor, hyperkinesia, limb tremor, torticollisUncommon (0.1% to 1%): Bradykinesia, cogwheel rigidity, dyskinesia, dystonia, dysarthriaFrequency not reported: Neuroleptic malignant syndrome, grand mal convulsion, tardive dyskinesia, electroencephalogram abnormal, motor restlessness, hyperreflexia, opisthotonos, drowsiness, sedation, speech disorder, handwriting change, taste change, akinesia, parkinsonism, faintingPostmarketing reports: Seizure
Extrapyramidal symptoms typically occurred during the first few days of treatment and involved mild to moderate Parkinson-like symptoms.  This disorder is usually dose-related, with an increased occurrence and severity of symptoms with high doses; symptoms decreased or disappeared with lower doses.  While these symptoms were usually reversible, a few cases of persistent symptoms required discontinuation.Grand mal seizures occurred at doses greater than 20 mg/day.
Very common (10% or more): Adverse behavior effect (up to 22.2%)Common (1% to 10%): Depression, agitation, insomnia, abnormal dreams, restlessness, nervousFrequency not reported: Libido decreased/lost, excitement
Sudden, unexpected deaths have occurred at doses greater than 20 mg/day.
Very common (10% or more): Asthenia (up to 13.8%)Common (1% to 10%): Extreme exhaustionUncommon (0.1% to 1%): Face edemaFrequency not reported: Neonatal drug withdrawal syndrome, body temperature dysregulation, hypothermiaPostmarketing reports: Sudden, unexplained death, hyperpyrexia, thirst
Very common (10% or more): Hyperhidrosis (up to 13%)Common (1% to 10%): Sebaceous gland overactivity, rashUncommon (less than 1%): PruritusFrequency not reported: Urticaria, skin irritation
Very common (10% or more): Nocturia (up to 12%)Common (1% to 10%): Urinary frequency, erectile dysfunctionUncommon (0.1% to 1%): AmenorrheaFrequency not reported: Galactorrhea, menstrual disorder, breast secretions, impotence
Common (1% to 10%): Constipation, dry mouth, vomiting, increased salivation/salivary hypersecretion, dysphagiaFrequency not reported: Diarrhea, nausea, gastrointestinal distressPostmarketing reports: Gingival hyperplasia
Gingival hyperplasia occurred in animal models at high doses, but was reversible after discontinuation.
Common (1% to 10%): Muscle rigidity, myalgiaUncommon (0.1% to 1%): Muscle spasmsFrequency not reported: Rigidity, neck rigidity, muscle cramps, muscle tightness, stooped posture
Common (1% to 10%): Vision blurred, visual disturbanceUncommon (0.1% to 1%): Oculogyric crisisFrequency not reported: Sensitivity of eyes to light, decrease accommodation, spots before eyes, periorbital edema, cataracts
Hyperglycemia occurred in patients with preexisting diabetes.
Common (1% to 10%): Anorexia, weight increasedFrequency not reported: Hyperglycemia, hyponatremia, appetite increase, weight loss
Electrocardiographic changes include prolongation of the QT interval, flattening/notching/inversion of the T wave, and the appearance of U waves.
Common (1% to 10%): ECG abnormalFrequency not reported: Torsade de Pointes, ventricular tachycardia/tachycardia, ventricular fibrillation, chest pain, postural hypotension/hypotension, hypertension, palpitationsPostmarketing reports: Cardiac arrest, venous thromboembolism, deep vein thrombosis
Frequency not reported: Blood prolactin increases, gynecomastia
Frequency not reported: Glycosuria
Postmarketing reports: Hemolytic anemia
Postmarketing reports: Pulmonary embolism
It is possible that some side effects of Orap may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Difficulty with speaking
dizziness or fainting
fast or irregular heartbeat
lack of facial expression
loss of balance control
mood or behavior changes
restlessness or need to keep moving
shuffling walk
slowed movements
stiffness of the arms and legs
swelling or soreness of the breasts (less common in males)
trembling and shaking of the fingers and hands
unusual secretion of milk (rare in males)
Difficulty with swallowing
inability to move the eyes
increased blinking or spasms of the eyelid
lip smacking or puckering
menstrual changes
muscle spasms, especially of the face, neck, or back
puffing of the cheeks
rapid or worm-like movements of the tongue
skin rash and itching
sore throat and fever
swelling of the face
uncontrolled chewing movements
uncontrolled movements of the neck, trunk, arms, or legs, including twisting movements
unusual bleeding or bruising
unusual facial expressions or body positions
yellow eyes or skin
Convulsions (seizures)
difficult or unusually fast breathing
fast heartbeat or irregular pulse
fever (high)
high or low (irregular) blood pressure
increased sweating
loss of bladder control
muscle stiffness (severe)
Coma
dizziness (severe)
muscle trembling, jerking, or stiffness (severe)
troubled breathing (severe)
uncontrolled movements (severe)
Blurred vision or other vision problems
constipation
dizziness, lightheadedness, or fainting when getting up from a lying or sitting position
drowsiness
dryness of the mouth
skin discoloration
Decreased sexual ability
diarrhea
headache
loss of appetite and weight
mental depression
nausea and vomiting
tiredness or weakness